Problem:
Merck wanted a website to highlight their approach to Biosimilars. This biological drug is like another natural drug (called the reference drug) that the FDA has approved. Our art direction and UX teams initially designed this in a variety of software (InDesign, Illustrator, and Photoshop). Then, the clients and developers suddenly wanted the whole website designed and made in Sketch, the new tool at the time.
My Impact:
I was responsible for converting the website from Photoshop and InDesign to Sketch App without using Avocode per client requirements. I worked with the Art, UX, and Asset Management teams with the design, navigation, development, and handoff of assets to the developers and the client. The website ended up being the first iteration of www.merckbiosimilars.com, which went live before being moved to Organon, a Merck subsidiary.
Homepage: Carousel Item 1
Homepage: Carousel Item 1
Homepage: Carousel Item 2
Homepage: Carousel Item 2
Homepage: Carousel Item 3
Homepage: Carousel Item 3
Homepage: Carousel Item 4
Homepage: Carousel Item 4
Potential of Biosimilars Page
Potential of Biosimilars Page
Adopting Biosimilars with Confidence Page
Adopting Biosimilars with Confidence Page
Want to see what the website looked like in full? You can view it on the Wayback Machine here.
Credits:
Art Direction: Jenny Woodward, Summer Snyder
Copywriter: Richard Levine
Back to Top